FDA Creating New Investment Opportunities in BioTech Stocks
Because FDA marketing clearance to sell a drug or device in the US remains the brass ring for medical manufacturers [...]
Because FDA marketing clearance to sell a drug or device in the US remains the brass ring for medical manufacturers [...]
Introducing SanaCurrents Introducing SanaCurrents, a research service for the serious and sophisticated biotech investor. Founder of SanaCurrents, Bill Langbein, finally [...]
Life science investing always has been a roller coaster ride, as well as a minefield, usually with more deep dips [...]
Summary Recently disclosed court documents show that Sinovac Biotech’s (NASDAQ: SVA) CEO bribed a member of the Chinese Food and [...]
Shares of Repro Med (OOTC:REPR) are little changed following the company's 2016 second quarter results. We view this as an encouraging [...]
One of the best performing stocks in our portfolio over the last couple years just gave away 50% of its [...]